Drugs and the cardiovascular system: The heart Flashcards
Name the cells which comprise the primary pacemaker site within the heart. Unlike most other cells that elicit action potentials, how is the depolarising current carried into these cells?
Sinoatrial (SA) nodal cells
- They are characterized as having no true resting potential, but instead generate regular, spontaneous action potentials
- The depolarizing current is carried into the cell primarily by relatively slow Ca2+ currents instead of by fast Na+ currents (no fast Na+ channels and currents operating in SA nodal cells)
SA nodal action potentials are divided into three phases. What do they each represent?
Phase 4 = the spontaneous depolarisation that triggers the action potential once the membrane potential reaches threshold
Phase 0 = depolarisation
Phase 3 = repolarisation; once the cell is completely repolarised at about -60 mV, the cycle is spontaneously repeated.
In the SA node, three ions are particularly important in generating the pacemaker action potential. State the role of these ions in the different action potential phases.
- At the end of phase 3, I(f) channels open that conduct slow, inward (depolarizing) Na+ currents = ‘funny’ currents (initiating phase 4)
- At about -50 mV membrane potential, transient or T-type Ca2+ channels open and the inward directed Ca2+ currents further depolarise the cell
- At about -40mV membrane potential, long-lasting or L-type Ca2+ channels open => more Ca2+ influx depolarises the cell further until threshold is reached.
- Phase 0 depolarisation is caused by increased Ca2+ influx through L-type channels (other channels close during this phase)
- Phase 3 repolarisation occurs as K+ channels open => K+ efflux; at the same time, the L-type Ca2+ channels become inactivated and close.
Although pacemaker activity is spontaneously generated by SA nodal cells, how can the rate of this activity be modified by SNS/PNS?
Sympathetic activation of the SA node (via noradrenaline acting on beta adrenoceptors which increase cAMP) increases pacemaker firing rate by increasing “funny” pacemaker currents (If) and increasing slow inward Ca2+ currents (the slope of phase 4 is steeper, which decreases the time to reach threshold)
Parasympathetic activation of the SA node (via ACh acting on muscarinic receptors, which decrease cAMP) decreases pacemaker firing rate by having opposite effects to above + increasing K+ efflux.
Stat the sequential steps that occur following membrane depolarisation (due to action potentials arising from the SA node) of a cardiac myocyte.
- Voltage-gated calcium channels (aka Dihydropyridine receptors) open => small release of Ca2+ into cell
- The small Ca2+ current induces Ca2+ release from the SR through ryanodine receptors
- Local release causes Ca2+ spark which sum up to create a Ca2+ signal
- Ca2+ binds to troponin to initiate contraction; relaxation occurs when Ca2+ unbinds
- Ca2+ is actively pumped back into SR and is also released from the cell via exchange with Na+
- Na+ gradient is maintained by the Na+/K+ ATPase pump
Which method is responsible for the majority of calcium removal?
SR ATPase uptake responsible for >70% of calcium removal
What regulates the action of the SR ATPase Ca2+ pump (SERCA) and how does it do this? State the consequences of upregulation in terms of rate of relaxation and contractility.
Phospholamban (PLN)
- Phospholamban phosphorylation by PKA is stimulated by beta-adrenergic activity
- When dephosphorylated it is an inhibitor of SERCA
- When phosphorylated it dissociates from SERCA and activates the Ca2+ pump
=> rate of cardiac relaxation is increased
=> increase in contractility is in proportion to the increase in the size of the SR calcium store
What are the determinants of myocardial oxygen supply?
Arterial oxygen content
Coronary blood flow
What are the determinants of myocardial oxygen demand?
Heart rate
Contractility
Preload
Afterload
Poor supply and high demand => angina
What effect do beta-blockers and calcium channel blockers have on the channels responsible for the SA node action potential, and hence heart rate? What effect do they have on contractility? What makes them excellent antianginal drugs?
- Beta-blockers decrease If and calcium channel activity
- Calcium channel blockers only decrease calcium channel activity
They both decrease heart rate and contractility which leads to a reduction in myocardial oxygen demand. CCBs can also dilate coronary arteries thereby increasing myocardial oxygen supply
Name a drug that decreases If channel activity. Does it affect contractility?
Ivabradine (blocks the If channel)
No
What are the two types of calcium channel blocker? Give examples of drugs in each category including their drug class.
Rate slowing which have cardiac and smooth muscle actions:
- Phenylalkylamines (e.g. verapamil)
- Benzothiazepines (e.g. diltiazem)
Non-rate slowing which only have smooth muscle actions:
- Dihydropyridines (e.g. amlodipine)
What is a consequence of non-rate slowing calcium channel blockers?
By blocking calcium entry into the smooth muscle cell => Profound systemic vasodilation => Reflex tachycardia (baroreceptor reflex)
How do organic nitrates cause vasodilation?
- Organic nitrates are substrates for nitric oxide production.
- NO activates smooth muscle soluble guanylyl cyclase (GC) to form cGMP.
- Increased intracellular cGMP inhibits calcium entry into the cell, thereby decreasing intracellular calcium concentrations and causing smooth muscle relaxation
- NO also activates K+ channels, which leads to hyperpolarization and relaxation.
Why are the organic nitrates useful in treating angina?
- Organic nitrates can dilate both arteries and veins (venous dilation > arterial dilation). Venous dilation reduces venous pressure and decreases ventricular preload. This reduces ventricular wall stress and oxygen demand by the heart, thereby enhancing the oxygen supply/demand ratio.
- Mild coronary dilation will further enhance the oxygen supply/demand ratio
- Systemic arterial dilation reduces afterload, which can enhance cardiac output while at the same time reducing ventricular wall stress and oxygen demand